Health & Fitness
Health and Fitness
Health and Fitness
Tue, June 21, 2011Mon, June 20, 2011Sun, June 19, 2011Fri, June 17, 2011Thu, June 16, 2011Wed, June 15, 2011Tue, June 14, 2011Mon, June 13, 2011Fri, June 10, 2011Thu, June 9, 2011Wed, June 8, 2011Tue, June 7, 2011Mon, June 6, 2011Sat, June 4, 2011Fri, June 3, 2011Thu, June 2, 2011Wed, June 1, 2011Tue, May 31, 2011Mon, May 30, 2011Fri, May 27, 2011Thu, May 26, 2011Wed, May 25, 2011Tue, May 24, 2011Mon, May 23, 2011Sun, May 22, 2011Fri, May 20, 2011Faruqi & Faruqi, LLP Is Investigating Eli Lilly & Co. - LLY
Published in Health and Fitness on Tuesday, June 7th 2011 at 17:40 GMT by Market Wire
NEW YORK--([ BUSINESS WIRE ])--Faruqi & Faruqi, LLP, a leading New York securities firm, is investigating the Board of Directors and Officers of Eli Lilly & Co. (aEli Lillya or the aCompanya) (NYSE: LLY). The investigation focuses on possible breaches of fiduciary duties by the Board of Directors and/or Officers of the Company in connection with allegations that the Company may have violated the Foreign Corrupt Practices Act (the aFCPAa). The FCPA prohibits U.S. publicly traded companies from promising, offering, or giving anything of value to foreign officials with the corrupt intent of influencing the foreign officials for the purpose of helping the company obtain or retain business or gain any improper advantage. The FCPA also imposes specific recordkeeping and internal controls requirements on U.S. publicly traded companies.
Request more information now by clicking here: [ www.faruqilaw.com/LLY ]
The Company recently disclosed that it is in advanced talks with the Securities and Exchange Commission (the aSECa) to resolve a probe into potential violations of the FCPA. Eli Lilly, maker of anti-psychotic Zyprexa and erectile-dysfunction treatment Cialis, was notified in 2003 that the SEC was investigating whether the Polish divisions of certain drug makers, including Eli Lilly, had violated the FCPA. The probe eventually widened to include Eli Lillya™s activities in other countries. The SEC has issued subpoenas requesting documents, and the U.S. Department of Justice also has asked Eli Lilly to provide information about activities in certain countries.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action and derivative litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firma™s clients.
If you own common stock in Eli Lilly and wish to obtain additional information, please visit us at [ http://www.faruqilaw.com/LLY ] or contact Beth A. Keller, Esq. either via email at [ bkeller@faruqilaw.com ] or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ([ www.faruqilaw.com ]). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.
